FACT OF THE DAY💡

Zolgensma is a gene therapy for spinal muscular atrophy that was introduced in the US at approximately $2.1 million for a single treatment, making it one of the world's most expensive medicines. It works by delivering a functional copy of the SMN1 gene and is designed as a one-time treatment.

#FOTD@The_MegaPlatform